<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:bc="http://www.brightcove.tv/link" xmlns:dcterms="http://purl.org/dc/terms/">
    <channel>
        <title>HealthDot Pharma Report 01</title>
        <link>http://link.brightcove.com/services/link/bcpid626942478?src=rss</link>
        <description>In this episode of the HealthDot Pharma Report we talk business with Ogilvy Healthworld's Frank Hone, explore Genentech's Macular Degeneration conundrum with Dr. William Rich, Medical Director of Health Policy at the American Academy of Opthalmology,</description>
        <copyright>Copyright 2009</copyright>
        <lastBuildDate>Mon, 23 Nov 2009 02:32:45 -0800</lastBuildDate>
        <generator>http://www.brightcove.com/?v=1.0</generator>
        <item>
            <title>HealthDot Pharma Report 01</title>
            <link>http://link.brightcove.com/services/link/bcpid626942478/bclid649461908/bctid626936824?src=rss</link>
            <description>&lt;img src="http://brightcove.vo.llnwd.net/d2/unsecured/media/29794487/29794487_510182857_8bb6e4f2a6d21f68ccb437616074f3cb8d6a664e.jpg?pubId=29794487"/&gt;In this episode of the HealthDot Pharma Report we talk business with Ogilvy Healthworld's Frank Hone, explore Genentech's Macular Degeneration conundrum with Dr. William Rich, Medical Director of Health Policy at the American Academy of Opthalmology,</description>
            <guid>http://link.brightcove.com/services/link/bcpid626942478/bclid649461908/bctid626936824?src=rss</guid>
            <pubDate>Thu, 15 Mar 2007 00:00:00 -0700</pubDate>
            <dcterms:valid/>
        </item>
    </channel>
</rss>

